Global Afatinib API Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Afatinib is an Active Pharmaceutical Ingredient (API) that serves as a selective, irreversible tyrosine kinase inhibitor used in cancer therapy. It is primarily indicated for the treatment of advanced non-small cell lung cancer with specific genetic mutations in the epidermal growth factor receptor (EGFR) gene.
The global Afatinib API market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Afatinib API Industry Forecast” looks at past sales and reviews total world Afatinib API sales in 2023, providing a comprehensive analysis by region and market sector of projected Afatinib API sales for 2024 through 2030. With Afatinib API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Afatinib API industry.
This Insight Report provides a comprehensive analysis of the global Afatinib API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Afatinib API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Afatinib API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Afatinib API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Afatinib API.
United States market for Afatinib API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Afatinib API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Afatinib API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Afatinib API players cover Shandong Anhong Pharmaceutical, Lianyungang Runzhong Pharmaceutical, Jiangsu Xidi Pharmaceuticals, Jiangsu Tasly Diyi Pharmaceutical, Fresenius Kabi, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Afatinib API market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Afatinib API market?
What factors are driving Afatinib API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Afatinib API market opportunities vary by end market size?
How does Afatinib API break out by Type, by Application?
Afatinib is an Active Pharmaceutical Ingredient (API) that serves as a selective, irreversible tyrosine kinase inhibitor used in cancer therapy. It is primarily indicated for the treatment of advanced non-small cell lung cancer with specific genetic mutations in the epidermal growth factor receptor (EGFR) gene.
The global Afatinib API market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Afatinib API Industry Forecast” looks at past sales and reviews total world Afatinib API sales in 2023, providing a comprehensive analysis by region and market sector of projected Afatinib API sales for 2024 through 2030. With Afatinib API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Afatinib API industry.
This Insight Report provides a comprehensive analysis of the global Afatinib API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Afatinib API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Afatinib API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Afatinib API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Afatinib API.
United States market for Afatinib API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Afatinib API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Afatinib API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Afatinib API players cover Shandong Anhong Pharmaceutical, Lianyungang Runzhong Pharmaceutical, Jiangsu Xidi Pharmaceuticals, Jiangsu Tasly Diyi Pharmaceutical, Fresenius Kabi, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Afatinib API market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Purity?99%
- Purity<99%
- Online Sales
- Offline Sales
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Shandong Anhong Pharmaceutical
- Lianyungang Runzhong Pharmaceutical
- Jiangsu Xidi Pharmaceuticals
- Jiangsu Tasly Diyi Pharmaceutical
- Fresenius Kabi
- Shilpa Medicare
- Clearsynth Labs
- MSN Laboratories
- Hetero Labs
- Alembic Pharmaceuticals
- Lotus International
- Caplin Point Laboratories
- Rmpl Pharma LLP
What is the 10-year outlook for the global Afatinib API market?
What factors are driving Afatinib API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Afatinib API market opportunities vary by end market size?
How does Afatinib API break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Afatinib API Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Afatinib API by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Afatinib API by Country/Region, 2019, 2023 & 2030
2.2 Afatinib API Segment by Type
2.2.1 Purity?99%
2.2.2 Purity<99%
2.3 Afatinib API Sales by Type
2.3.1 Global Afatinib API Sales Market Share by Type (2019-2024)
2.3.2 Global Afatinib API Revenue and Market Share by Type (2019-2024)
2.3.3 Global Afatinib API Sale Price by Type (2019-2024)
2.4 Afatinib API Segment by Application
2.4.1 Online Sales
2.4.2 Offline Sales
2.5 Afatinib API Sales by Application
2.5.1 Global Afatinib API Sale Market Share by Application (2019-2024)
2.5.2 Global Afatinib API Revenue and Market Share by Application (2019-2024)
2.5.3 Global Afatinib API Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Afatinib API Breakdown Data by Company
3.1.1 Global Afatinib API Annual Sales by Company (2019-2024)
3.1.2 Global Afatinib API Sales Market Share by Company (2019-2024)
3.2 Global Afatinib API Annual Revenue by Company (2019-2024)
3.2.1 Global Afatinib API Revenue by Company (2019-2024)
3.2.2 Global Afatinib API Revenue Market Share by Company (2019-2024)
3.3 Global Afatinib API Sale Price by Company
3.4 Key Manufacturers Afatinib API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Afatinib API Product Location Distribution
3.4.2 Players Afatinib API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR AFATINIB API BY GEOGRAPHIC REGION
4.1 World Historic Afatinib API Market Size by Geographic Region (2019-2024)
4.1.1 Global Afatinib API Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Afatinib API Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Afatinib API Market Size by Country/Region (2019-2024)
4.2.1 Global Afatinib API Annual Sales by Country/Region (2019-2024)
4.2.2 Global Afatinib API Annual Revenue by Country/Region (2019-2024)
4.3 Americas Afatinib API Sales Growth
4.4 APAC Afatinib API Sales Growth
4.5 Europe Afatinib API Sales Growth
4.6 Middle East & Africa Afatinib API Sales Growth
5 AMERICAS
5.1 Americas Afatinib API Sales by Country
5.1.1 Americas Afatinib API Sales by Country (2019-2024)
5.1.2 Americas Afatinib API Revenue by Country (2019-2024)
5.2 Americas Afatinib API Sales by Type (2019-2024)
5.3 Americas Afatinib API Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Afatinib API Sales by Region
6.1.1 APAC Afatinib API Sales by Region (2019-2024)
6.1.2 APAC Afatinib API Revenue by Region (2019-2024)
6.2 APAC Afatinib API Sales by Type (2019-2024)
6.3 APAC Afatinib API Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Afatinib API by Country
7.1.1 Europe Afatinib API Sales by Country (2019-2024)
7.1.2 Europe Afatinib API Revenue by Country (2019-2024)
7.2 Europe Afatinib API Sales by Type (2019-2024)
7.3 Europe Afatinib API Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Afatinib API by Country
8.1.1 Middle East & Africa Afatinib API Sales by Country (2019-2024)
8.1.2 Middle East & Africa Afatinib API Revenue by Country (2019-2024)
8.2 Middle East & Africa Afatinib API Sales by Type (2019-2024)
8.3 Middle East & Africa Afatinib API Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Afatinib API
10.3 Manufacturing Process Analysis of Afatinib API
10.4 Industry Chain Structure of Afatinib API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Afatinib API Distributors
11.3 Afatinib API Customer
12 WORLD FORECAST REVIEW FOR AFATINIB API BY GEOGRAPHIC REGION
12.1 Global Afatinib API Market Size Forecast by Region
12.1.1 Global Afatinib API Forecast by Region (2025-2030)
12.1.2 Global Afatinib API Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Afatinib API Forecast by Type (2025-2030)
12.7 Global Afatinib API Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Shandong Anhong Pharmaceutical
13.1.1 Shandong Anhong Pharmaceutical Company Information
13.1.2 Shandong Anhong Pharmaceutical Afatinib API Product Portfolios and Specifications
13.1.3 Shandong Anhong Pharmaceutical Afatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Shandong Anhong Pharmaceutical Main Business Overview
13.1.5 Shandong Anhong Pharmaceutical Latest Developments
13.2 Lianyungang Runzhong Pharmaceutical
13.2.1 Lianyungang Runzhong Pharmaceutical Company Information
13.2.2 Lianyungang Runzhong Pharmaceutical Afatinib API Product Portfolios and Specifications
13.2.3 Lianyungang Runzhong Pharmaceutical Afatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Lianyungang Runzhong Pharmaceutical Main Business Overview
13.2.5 Lianyungang Runzhong Pharmaceutical Latest Developments
13.3 Jiangsu Xidi Pharmaceuticals
13.3.1 Jiangsu Xidi Pharmaceuticals Company Information
13.3.2 Jiangsu Xidi Pharmaceuticals Afatinib API Product Portfolios and Specifications
13.3.3 Jiangsu Xidi Pharmaceuticals Afatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Jiangsu Xidi Pharmaceuticals Main Business Overview
13.3.5 Jiangsu Xidi Pharmaceuticals Latest Developments
13.4 Jiangsu Tasly Diyi Pharmaceutical
13.4.1 Jiangsu Tasly Diyi Pharmaceutical Company Information
13.4.2 Jiangsu Tasly Diyi Pharmaceutical Afatinib API Product Portfolios and Specifications
13.4.3 Jiangsu Tasly Diyi Pharmaceutical Afatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Jiangsu Tasly Diyi Pharmaceutical Main Business Overview
13.4.5 Jiangsu Tasly Diyi Pharmaceutical Latest Developments
13.5 Fresenius Kabi
13.5.1 Fresenius Kabi Company Information
13.5.2 Fresenius Kabi Afatinib API Product Portfolios and Specifications
13.5.3 Fresenius Kabi Afatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Fresenius Kabi Main Business Overview
13.5.5 Fresenius Kabi Latest Developments
13.6 Shilpa Medicare
13.6.1 Shilpa Medicare Company Information
13.6.2 Shilpa Medicare Afatinib API Product Portfolios and Specifications
13.6.3 Shilpa Medicare Afatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Shilpa Medicare Main Business Overview
13.6.5 Shilpa Medicare Latest Developments
13.7 Clearsynth Labs
13.7.1 Clearsynth Labs Company Information
13.7.2 Clearsynth Labs Afatinib API Product Portfolios and Specifications
13.7.3 Clearsynth Labs Afatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Clearsynth Labs Main Business Overview
13.7.5 Clearsynth Labs Latest Developments
13.8 MSN Laboratories
13.8.1 MSN Laboratories Company Information
13.8.2 MSN Laboratories Afatinib API Product Portfolios and Specifications
13.8.3 MSN Laboratories Afatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 MSN Laboratories Main Business Overview
13.8.5 MSN Laboratories Latest Developments
13.9 Hetero Labs
13.9.1 Hetero Labs Company Information
13.9.2 Hetero Labs Afatinib API Product Portfolios and Specifications
13.9.3 Hetero Labs Afatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Hetero Labs Main Business Overview
13.9.5 Hetero Labs Latest Developments
13.10 Alembic Pharmaceuticals
13.10.1 Alembic Pharmaceuticals Company Information
13.10.2 Alembic Pharmaceuticals Afatinib API Product Portfolios and Specifications
13.10.3 Alembic Pharmaceuticals Afatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Alembic Pharmaceuticals Main Business Overview
13.10.5 Alembic Pharmaceuticals Latest Developments
13.11 Lotus International
13.11.1 Lotus International Company Information
13.11.2 Lotus International Afatinib API Product Portfolios and Specifications
13.11.3 Lotus International Afatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Lotus International Main Business Overview
13.11.5 Lotus International Latest Developments
13.12 Caplin Point Laboratories
13.12.1 Caplin Point Laboratories Company Information
13.12.2 Caplin Point Laboratories Afatinib API Product Portfolios and Specifications
13.12.3 Caplin Point Laboratories Afatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Caplin Point Laboratories Main Business Overview
13.12.5 Caplin Point Laboratories Latest Developments
13.13 Rmpl Pharma LLP
13.13.1 Rmpl Pharma LLP Company Information
13.13.2 Rmpl Pharma LLP Afatinib API Product Portfolios and Specifications
13.13.3 Rmpl Pharma LLP Afatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Rmpl Pharma LLP Main Business Overview
13.13.5 Rmpl Pharma LLP Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Afatinib API Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Afatinib API Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Purity?99%
Table 4. Major Players of Purity<99%
Table 5. Global Afatinib API Sales byType (2019-2024) & (Tons)
Table 6. Global Afatinib API Sales Market Share byType (2019-2024)
Table 7. Global Afatinib API Revenue byType (2019-2024) & ($ million)
Table 8. Global Afatinib API Revenue Market Share byType (2019-2024)
Table 9. Global Afatinib API Sale Price byType (2019-2024) & (US$/kg)
Table 10. Global Afatinib API Sale by Application (2019-2024) & (Tons)
Table 11. Global Afatinib API Sale Market Share by Application (2019-2024)
Table 12. Global Afatinib API Revenue by Application (2019-2024) & ($ million)
Table 13. Global Afatinib API Revenue Market Share by Application (2019-2024)
Table 14. Global Afatinib API Sale Price by Application (2019-2024) & (US$/kg)
Table 15. Global Afatinib API Sales by Company (2019-2024) & (Tons)
Table 16. Global Afatinib API Sales Market Share by Company (2019-2024)
Table 17. Global Afatinib API Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Afatinib API Revenue Market Share by Company (2019-2024)
Table 19. Global Afatinib API Sale Price by Company (2019-2024) & (US$/kg)
Table 20. Key Manufacturers Afatinib API Producing Area Distribution and Sales Area
Table 21. Players Afatinib API Products Offered
Table 22. Afatinib API Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Afatinib API Sales by Geographic Region (2019-2024) & (Tons)
Table 26. Global Afatinib API Sales Market Share Geographic Region (2019-2024)
Table 27. Global Afatinib API Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Afatinib API Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Afatinib API Sales by Country/Region (2019-2024) & (Tons)
Table 30. Global Afatinib API Sales Market Share by Country/Region (2019-2024)
Table 31. Global Afatinib API Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Afatinib API Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Afatinib API Sales by Country (2019-2024) & (Tons)
Table 34. Americas Afatinib API Sales Market Share by Country (2019-2024)
Table 35. Americas Afatinib API Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Afatinib API Sales byType (2019-2024) & (Tons)
Table 37. Americas Afatinib API Sales by Application (2019-2024) & (Tons)
Table 38. APAC Afatinib API Sales by Region (2019-2024) & (Tons)
Table 39. APAC Afatinib API Sales Market Share by Region (2019-2024)
Table 40. APAC Afatinib API Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Afatinib API Sales byType (2019-2024) & (Tons)
Table 42. APAC Afatinib API Sales by Application (2019-2024) & (Tons)
Table 43. Europe Afatinib API Sales by Country (2019-2024) & (Tons)
Table 44. Europe Afatinib API Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Afatinib API Sales byType (2019-2024) & (Tons)
Table 46. Europe Afatinib API Sales by Application (2019-2024) & (Tons)
Table 47. Middle East & Africa Afatinib API Sales by Country (2019-2024) & (Tons)
Table 48. Middle East & Africa Afatinib API Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Afatinib API Sales byType (2019-2024) & (Tons)
Table 50. Middle East & Africa Afatinib API Sales by Application (2019-2024) & (Tons)
Table 51. Key Market Drivers & Growth Opportunities of Afatinib API
Table 52. Key Market Challenges & Risks of Afatinib API
Table 53. Key IndustryTrends of Afatinib API
Table 54. Afatinib API Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Afatinib API Distributors List
Table 57. Afatinib API Customer List
Table 58. Global Afatinib API SalesForecast by Region (2025-2030) & (Tons)
Table 59. Global Afatinib API RevenueForecast by Region (2025-2030) & ($ millions)
Table 60. Americas Afatinib API SalesForecast by Country (2025-2030) & (Tons)
Table 61. Americas Afatinib API Annual RevenueForecast by Country (2025-2030) & ($ millions)
Table 62. APAC Afatinib API SalesForecast by Region (2025-2030) & (Tons)
Table 63. APAC Afatinib API Annual RevenueForecast by Region (2025-2030) & ($ millions)
Table 64. Europe Afatinib API SalesForecast by Country (2025-2030) & (Tons)
Table 65. Europe Afatinib API RevenueForecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Afatinib API SalesForecast by Country (2025-2030) & (Tons)
Table 67. Middle East & Africa Afatinib API RevenueForecast by Country (2025-2030) & ($ millions)
Table 68. Global Afatinib API SalesForecast byType (2025-2030) & (Tons)
Table 69. Global Afatinib API RevenueForecast byType (2025-2030) & ($ millions)
Table 70. Global Afatinib API SalesForecast by Application (2025-2030) & (Tons)
Table 71. Global Afatinib API RevenueForecast by Application (2025-2030) & ($ millions)
Table 72. Shandong Anhong Pharmaceutical Basic Information, Afatinib API Manufacturing Base, Sales Area and Its Competitors
Table 73. Shandong Anhong Pharmaceutical Afatinib API Product Portfolios and Specifications
Table 74. Shandong Anhong Pharmaceutical Afatinib API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 75. Shandong Anhong Pharmaceutical Main Business
Table 76. Shandong Anhong Pharmaceutical Latest Developments
Table 77. Lianyungang Runzhong Pharmaceutical Basic Information, Afatinib API Manufacturing Base, Sales Area and Its Competitors
Table 78. Lianyungang Runzhong Pharmaceutical Afatinib API Product Portfolios and Specifications
Table 79. Lianyungang Runzhong Pharmaceutical Afatinib API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 80. Lianyungang Runzhong Pharmaceutical Main Business
Table 81. Lianyungang Runzhong Pharmaceutical Latest Developments
Table 82. Jiangsu Xidi Pharmaceuticals Basic Information, Afatinib API Manufacturing Base, Sales Area and Its Competitors
Table 83. Jiangsu Xidi Pharmaceuticals Afatinib API Product Portfolios and Specifications
Table 84. Jiangsu Xidi Pharmaceuticals Afatinib API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 85. Jiangsu Xidi Pharmaceuticals Main Business
Table 86. Jiangsu Xidi Pharmaceuticals Latest Developments
Table 87. JiangsuTasly Diyi Pharmaceutical Basic Information, Afatinib API Manufacturing Base, Sales Area and Its Competitors
Table 88. JiangsuTasly Diyi Pharmaceutical Afatinib API Product Portfolios and Specifications
Table 89. JiangsuTasly Diyi Pharmaceutical Afatinib API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 90. JiangsuTasly Diyi Pharmaceutical Main Business
Table 91. JiangsuTasly Diyi Pharmaceutical Latest Developments
Table 92.Fresenius Kabi Basic Information, Afatinib API Manufacturing Base, Sales Area and Its Competitors
Table 93.Fresenius Kabi Afatinib API Product Portfolios and Specifications
Table 94.Fresenius Kabi Afatinib API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 95.Fresenius Kabi Main Business
Table 96.Fresenius Kabi Latest Developments
Table 97. Shilpa Medicare Basic Information, Afatinib API Manufacturing Base, Sales Area and Its Competitors
Table 98. Shilpa Medicare Afatinib API Product Portfolios and Specifications
Table 99. Shilpa Medicare Afatinib API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 100. Shilpa Medicare Main Business
Table 101. Shilpa Medicare Latest Developments
Table 102. Clearsynth Labs Basic Information, Afatinib API Manufacturing Base, Sales Area and Its Competitors
Table 103. Clearsynth Labs Afatinib API Product Portfolios and Specifications
Table 104. Clearsynth Labs Afatinib API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 105. Clearsynth Labs Main Business
Table 106. Clearsynth Labs Latest Developments
Table 107. MSN Laboratories Basic Information, Afatinib API Manufacturing Base, Sales Area and Its Competitors
Table 108. MSN Laboratories Afatinib API Product Portfolios and Specifications
Table 109. MSN Laboratories Afatinib API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 110. MSN Laboratories Main Business
Table 111. MSN Laboratories Latest Developments
Table 112. Hetero Labs Basic Information, Afatinib API Manufacturing Base, Sales Area and Its Competitors
Table 113. Hetero Labs Afatinib API Product Portfolios and Specifications
Table 114. Hetero Labs Afatinib API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 115. Hetero Labs Main Business
Table 116. Hetero Labs Latest Developments
Table 117. Alembic Pharmaceuticals Basic Information, Afatinib API Manufacturing Base, Sales Area and Its Competitors
Table 118. Alembic Pharmaceuticals Afatinib API Product Portfolios and Specifications
Table 119. Alembic Pharmaceuticals Afatinib API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 120. Alembic Pharmaceuticals Main Business
Table 121. Alembic Pharmaceuticals Latest Developments
Table 122. Lotus International Basic Information, Afatinib API Manufacturing Base, Sales Area and Its Competitors
Table 123. Lotus International Afatinib API Product Portfolios and Specifications
Table 124. Lotus International Afatinib API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 125. Lotus International Main Business
Table 126. Lotus International Latest Developments
Table 127. Caplin Point Laboratories Basic Information, Afatinib API Manufacturing Base, Sales Area and Its Competitors
Table 128. Caplin Point Laboratories Afatinib API Product Portfolios and Specifications
Table 129. Caplin Point Laboratories Afatinib API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 130. Caplin Point Laboratories Main Business
Table 131. Caplin Point Laboratories Latest Developments
Table 132. Rmpl Pharma LLP Basic Information, Afatinib API Manufacturing Base, Sales Area and Its Competitors
Table 133. Rmpl Pharma LLP Afatinib API Product Portfolios and Specifications
Table 134. Rmpl Pharma LLP Afatinib API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 135. Rmpl Pharma LLP Main Business
Table 136. Rmpl Pharma LLP Latest Developments
LIST OFFIGURES
Figure 1. Picture of Afatinib API
Figure 2. Afatinib API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Afatinib API Sales Growth Rate 2019-2030 (Tons)
Figure 7. Global Afatinib API Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Afatinib API Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Afatinib API Sales Market Share by Country/Region (2023)
Figure 10. Afatinib API Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Purity?99%
Figure 12. Product Picture of Purity<99%
Figure 13. Global Afatinib API Sales Market Share byType in 2023
Figure 14. Global Afatinib API Revenue Market Share byType (2019-2024)
Figure 15. Afatinib API Consumed in Online Sales
Figure 16. Global Afatinib API Market: Online Sales (2019-2024) & (Tons)
Figure 17. Afatinib API Consumed in Offline Sales
Figure 18. Global Afatinib API Market: Offline Sales (2019-2024) & (Tons)
Figure 19. Global Afatinib API Sale Market Share by Application (2023)
Figure 20. Global Afatinib API Revenue Market Share by Application in 2023
Figure 21. Afatinib API Sales by Company in 2023 (Tons)
Figure 22. Global Afatinib API Sales Market Share by Company in 2023
Figure 23. Afatinib API Revenue by Company in 2023 ($ millions)
Figure 24. Global Afatinib API Revenue Market Share by Company in 2023
Figure 25. Global Afatinib API Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Afatinib API Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Afatinib API Sales 2019-2024 (Tons)
Figure 28. Americas Afatinib API Revenue 2019-2024 ($ millions)
Figure 29. APAC Afatinib API Sales 2019-2024 (Tons)
Figure 30. APAC Afatinib API Revenue 2019-2024 ($ millions)
Figure 31. Europe Afatinib API Sales 2019-2024 (Tons)
Figure 32. Europe Afatinib API Revenue 2019-2024 ($ millions)
Figure 33. Middle East & Africa Afatinib API Sales 2019-2024 (Tons)
Figure 34. Middle East & Africa Afatinib API Revenue 2019-2024 ($ millions)
Figure 35. Americas Afatinib API Sales Market Share by Country in 2023
Figure 36. Americas Afatinib API Revenue Market Share by Country (2019-2024)
Figure 37. Americas Afatinib API Sales Market Share byType (2019-2024)
Figure 38. Americas Afatinib API Sales Market Share by Application (2019-2024)
Figure 39. United States Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 40. Canada Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 41. Mexico Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 42. Brazil Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 43. APAC Afatinib API Sales Market Share by Region in 2023
Figure 44. APAC Afatinib API Revenue Market Share by Region (2019-2024)
Figure 45. APAC Afatinib API Sales Market Share byType (2019-2024)
Figure 46. APAC Afatinib API Sales Market Share by Application (2019-2024)
Figure 47. China Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 48. Japan Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 49. South Korea Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 50. Southeast Asia Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 51. India Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 52. Australia Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 53. ChinaTaiwan Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 54. Europe Afatinib API Sales Market Share by Country in 2023
Figure 55. Europe Afatinib API Revenue Market Share by Country (2019-2024)
Figure 56. Europe Afatinib API Sales Market Share byType (2019-2024)
Figure 57. Europe Afatinib API Sales Market Share by Application (2019-2024)
Figure 58. Germany Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 59.France Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 60. UK Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 61. Italy Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 62. Russia Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 63. Middle East & Africa Afatinib API Sales Market Share by Country (2019-2024)
Figure 64. Middle East & Africa Afatinib API Sales Market Share byType (2019-2024)
Figure 65. Middle East & Africa Afatinib API Sales Market Share by Application (2019-2024)
Figure 66. Egypt Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 67. South Africa Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 68. Israel Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 69.Turkey Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 70. GCC Countries Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Afatinib API in 2023
Figure 72. Manufacturing Process Analysis of Afatinib API
Figure 73. Industry Chain Structure of Afatinib API
Figure 74. Channels of Distribution
Figure 75. Global Afatinib API Sales MarketForecast by Region (2025-2030)
Figure 76. Global Afatinib API Revenue Market ShareForecast by Region (2025-2030)
Figure 77. Global Afatinib API Sales Market ShareForecast byType (2025-2030)
Figure 78. Global Afatinib API Revenue Market ShareForecast byType (2025-2030)
Figure 79. Global Afatinib API Sales Market ShareForecast by Application (2025-2030)
Figure 80. Global Afatinib API Revenue Market ShareForecast by Application (2025-2030)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Afatinib API Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Afatinib API by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Afatinib API by Country/Region, 2019, 2023 & 2030
2.2 Afatinib API Segment by Type
2.2.1 Purity?99%
2.2.2 Purity<99%
2.3 Afatinib API Sales by Type
2.3.1 Global Afatinib API Sales Market Share by Type (2019-2024)
2.3.2 Global Afatinib API Revenue and Market Share by Type (2019-2024)
2.3.3 Global Afatinib API Sale Price by Type (2019-2024)
2.4 Afatinib API Segment by Application
2.4.1 Online Sales
2.4.2 Offline Sales
2.5 Afatinib API Sales by Application
2.5.1 Global Afatinib API Sale Market Share by Application (2019-2024)
2.5.2 Global Afatinib API Revenue and Market Share by Application (2019-2024)
2.5.3 Global Afatinib API Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Afatinib API Breakdown Data by Company
3.1.1 Global Afatinib API Annual Sales by Company (2019-2024)
3.1.2 Global Afatinib API Sales Market Share by Company (2019-2024)
3.2 Global Afatinib API Annual Revenue by Company (2019-2024)
3.2.1 Global Afatinib API Revenue by Company (2019-2024)
3.2.2 Global Afatinib API Revenue Market Share by Company (2019-2024)
3.3 Global Afatinib API Sale Price by Company
3.4 Key Manufacturers Afatinib API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Afatinib API Product Location Distribution
3.4.2 Players Afatinib API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR AFATINIB API BY GEOGRAPHIC REGION
4.1 World Historic Afatinib API Market Size by Geographic Region (2019-2024)
4.1.1 Global Afatinib API Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Afatinib API Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Afatinib API Market Size by Country/Region (2019-2024)
4.2.1 Global Afatinib API Annual Sales by Country/Region (2019-2024)
4.2.2 Global Afatinib API Annual Revenue by Country/Region (2019-2024)
4.3 Americas Afatinib API Sales Growth
4.4 APAC Afatinib API Sales Growth
4.5 Europe Afatinib API Sales Growth
4.6 Middle East & Africa Afatinib API Sales Growth
5 AMERICAS
5.1 Americas Afatinib API Sales by Country
5.1.1 Americas Afatinib API Sales by Country (2019-2024)
5.1.2 Americas Afatinib API Revenue by Country (2019-2024)
5.2 Americas Afatinib API Sales by Type (2019-2024)
5.3 Americas Afatinib API Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Afatinib API Sales by Region
6.1.1 APAC Afatinib API Sales by Region (2019-2024)
6.1.2 APAC Afatinib API Revenue by Region (2019-2024)
6.2 APAC Afatinib API Sales by Type (2019-2024)
6.3 APAC Afatinib API Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Afatinib API by Country
7.1.1 Europe Afatinib API Sales by Country (2019-2024)
7.1.2 Europe Afatinib API Revenue by Country (2019-2024)
7.2 Europe Afatinib API Sales by Type (2019-2024)
7.3 Europe Afatinib API Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Afatinib API by Country
8.1.1 Middle East & Africa Afatinib API Sales by Country (2019-2024)
8.1.2 Middle East & Africa Afatinib API Revenue by Country (2019-2024)
8.2 Middle East & Africa Afatinib API Sales by Type (2019-2024)
8.3 Middle East & Africa Afatinib API Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Afatinib API
10.3 Manufacturing Process Analysis of Afatinib API
10.4 Industry Chain Structure of Afatinib API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Afatinib API Distributors
11.3 Afatinib API Customer
12 WORLD FORECAST REVIEW FOR AFATINIB API BY GEOGRAPHIC REGION
12.1 Global Afatinib API Market Size Forecast by Region
12.1.1 Global Afatinib API Forecast by Region (2025-2030)
12.1.2 Global Afatinib API Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Afatinib API Forecast by Type (2025-2030)
12.7 Global Afatinib API Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Shandong Anhong Pharmaceutical
13.1.1 Shandong Anhong Pharmaceutical Company Information
13.1.2 Shandong Anhong Pharmaceutical Afatinib API Product Portfolios and Specifications
13.1.3 Shandong Anhong Pharmaceutical Afatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Shandong Anhong Pharmaceutical Main Business Overview
13.1.5 Shandong Anhong Pharmaceutical Latest Developments
13.2 Lianyungang Runzhong Pharmaceutical
13.2.1 Lianyungang Runzhong Pharmaceutical Company Information
13.2.2 Lianyungang Runzhong Pharmaceutical Afatinib API Product Portfolios and Specifications
13.2.3 Lianyungang Runzhong Pharmaceutical Afatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Lianyungang Runzhong Pharmaceutical Main Business Overview
13.2.5 Lianyungang Runzhong Pharmaceutical Latest Developments
13.3 Jiangsu Xidi Pharmaceuticals
13.3.1 Jiangsu Xidi Pharmaceuticals Company Information
13.3.2 Jiangsu Xidi Pharmaceuticals Afatinib API Product Portfolios and Specifications
13.3.3 Jiangsu Xidi Pharmaceuticals Afatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Jiangsu Xidi Pharmaceuticals Main Business Overview
13.3.5 Jiangsu Xidi Pharmaceuticals Latest Developments
13.4 Jiangsu Tasly Diyi Pharmaceutical
13.4.1 Jiangsu Tasly Diyi Pharmaceutical Company Information
13.4.2 Jiangsu Tasly Diyi Pharmaceutical Afatinib API Product Portfolios and Specifications
13.4.3 Jiangsu Tasly Diyi Pharmaceutical Afatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Jiangsu Tasly Diyi Pharmaceutical Main Business Overview
13.4.5 Jiangsu Tasly Diyi Pharmaceutical Latest Developments
13.5 Fresenius Kabi
13.5.1 Fresenius Kabi Company Information
13.5.2 Fresenius Kabi Afatinib API Product Portfolios and Specifications
13.5.3 Fresenius Kabi Afatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Fresenius Kabi Main Business Overview
13.5.5 Fresenius Kabi Latest Developments
13.6 Shilpa Medicare
13.6.1 Shilpa Medicare Company Information
13.6.2 Shilpa Medicare Afatinib API Product Portfolios and Specifications
13.6.3 Shilpa Medicare Afatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Shilpa Medicare Main Business Overview
13.6.5 Shilpa Medicare Latest Developments
13.7 Clearsynth Labs
13.7.1 Clearsynth Labs Company Information
13.7.2 Clearsynth Labs Afatinib API Product Portfolios and Specifications
13.7.3 Clearsynth Labs Afatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Clearsynth Labs Main Business Overview
13.7.5 Clearsynth Labs Latest Developments
13.8 MSN Laboratories
13.8.1 MSN Laboratories Company Information
13.8.2 MSN Laboratories Afatinib API Product Portfolios and Specifications
13.8.3 MSN Laboratories Afatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 MSN Laboratories Main Business Overview
13.8.5 MSN Laboratories Latest Developments
13.9 Hetero Labs
13.9.1 Hetero Labs Company Information
13.9.2 Hetero Labs Afatinib API Product Portfolios and Specifications
13.9.3 Hetero Labs Afatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Hetero Labs Main Business Overview
13.9.5 Hetero Labs Latest Developments
13.10 Alembic Pharmaceuticals
13.10.1 Alembic Pharmaceuticals Company Information
13.10.2 Alembic Pharmaceuticals Afatinib API Product Portfolios and Specifications
13.10.3 Alembic Pharmaceuticals Afatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Alembic Pharmaceuticals Main Business Overview
13.10.5 Alembic Pharmaceuticals Latest Developments
13.11 Lotus International
13.11.1 Lotus International Company Information
13.11.2 Lotus International Afatinib API Product Portfolios and Specifications
13.11.3 Lotus International Afatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Lotus International Main Business Overview
13.11.5 Lotus International Latest Developments
13.12 Caplin Point Laboratories
13.12.1 Caplin Point Laboratories Company Information
13.12.2 Caplin Point Laboratories Afatinib API Product Portfolios and Specifications
13.12.3 Caplin Point Laboratories Afatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Caplin Point Laboratories Main Business Overview
13.12.5 Caplin Point Laboratories Latest Developments
13.13 Rmpl Pharma LLP
13.13.1 Rmpl Pharma LLP Company Information
13.13.2 Rmpl Pharma LLP Afatinib API Product Portfolios and Specifications
13.13.3 Rmpl Pharma LLP Afatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Rmpl Pharma LLP Main Business Overview
13.13.5 Rmpl Pharma LLP Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Afatinib API Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Afatinib API Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Purity?99%
Table 4. Major Players of Purity<99%
Table 5. Global Afatinib API Sales byType (2019-2024) & (Tons)
Table 6. Global Afatinib API Sales Market Share byType (2019-2024)
Table 7. Global Afatinib API Revenue byType (2019-2024) & ($ million)
Table 8. Global Afatinib API Revenue Market Share byType (2019-2024)
Table 9. Global Afatinib API Sale Price byType (2019-2024) & (US$/kg)
Table 10. Global Afatinib API Sale by Application (2019-2024) & (Tons)
Table 11. Global Afatinib API Sale Market Share by Application (2019-2024)
Table 12. Global Afatinib API Revenue by Application (2019-2024) & ($ million)
Table 13. Global Afatinib API Revenue Market Share by Application (2019-2024)
Table 14. Global Afatinib API Sale Price by Application (2019-2024) & (US$/kg)
Table 15. Global Afatinib API Sales by Company (2019-2024) & (Tons)
Table 16. Global Afatinib API Sales Market Share by Company (2019-2024)
Table 17. Global Afatinib API Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Afatinib API Revenue Market Share by Company (2019-2024)
Table 19. Global Afatinib API Sale Price by Company (2019-2024) & (US$/kg)
Table 20. Key Manufacturers Afatinib API Producing Area Distribution and Sales Area
Table 21. Players Afatinib API Products Offered
Table 22. Afatinib API Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Afatinib API Sales by Geographic Region (2019-2024) & (Tons)
Table 26. Global Afatinib API Sales Market Share Geographic Region (2019-2024)
Table 27. Global Afatinib API Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Afatinib API Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Afatinib API Sales by Country/Region (2019-2024) & (Tons)
Table 30. Global Afatinib API Sales Market Share by Country/Region (2019-2024)
Table 31. Global Afatinib API Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Afatinib API Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Afatinib API Sales by Country (2019-2024) & (Tons)
Table 34. Americas Afatinib API Sales Market Share by Country (2019-2024)
Table 35. Americas Afatinib API Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Afatinib API Sales byType (2019-2024) & (Tons)
Table 37. Americas Afatinib API Sales by Application (2019-2024) & (Tons)
Table 38. APAC Afatinib API Sales by Region (2019-2024) & (Tons)
Table 39. APAC Afatinib API Sales Market Share by Region (2019-2024)
Table 40. APAC Afatinib API Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Afatinib API Sales byType (2019-2024) & (Tons)
Table 42. APAC Afatinib API Sales by Application (2019-2024) & (Tons)
Table 43. Europe Afatinib API Sales by Country (2019-2024) & (Tons)
Table 44. Europe Afatinib API Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Afatinib API Sales byType (2019-2024) & (Tons)
Table 46. Europe Afatinib API Sales by Application (2019-2024) & (Tons)
Table 47. Middle East & Africa Afatinib API Sales by Country (2019-2024) & (Tons)
Table 48. Middle East & Africa Afatinib API Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Afatinib API Sales byType (2019-2024) & (Tons)
Table 50. Middle East & Africa Afatinib API Sales by Application (2019-2024) & (Tons)
Table 51. Key Market Drivers & Growth Opportunities of Afatinib API
Table 52. Key Market Challenges & Risks of Afatinib API
Table 53. Key IndustryTrends of Afatinib API
Table 54. Afatinib API Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Afatinib API Distributors List
Table 57. Afatinib API Customer List
Table 58. Global Afatinib API SalesForecast by Region (2025-2030) & (Tons)
Table 59. Global Afatinib API RevenueForecast by Region (2025-2030) & ($ millions)
Table 60. Americas Afatinib API SalesForecast by Country (2025-2030) & (Tons)
Table 61. Americas Afatinib API Annual RevenueForecast by Country (2025-2030) & ($ millions)
Table 62. APAC Afatinib API SalesForecast by Region (2025-2030) & (Tons)
Table 63. APAC Afatinib API Annual RevenueForecast by Region (2025-2030) & ($ millions)
Table 64. Europe Afatinib API SalesForecast by Country (2025-2030) & (Tons)
Table 65. Europe Afatinib API RevenueForecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Afatinib API SalesForecast by Country (2025-2030) & (Tons)
Table 67. Middle East & Africa Afatinib API RevenueForecast by Country (2025-2030) & ($ millions)
Table 68. Global Afatinib API SalesForecast byType (2025-2030) & (Tons)
Table 69. Global Afatinib API RevenueForecast byType (2025-2030) & ($ millions)
Table 70. Global Afatinib API SalesForecast by Application (2025-2030) & (Tons)
Table 71. Global Afatinib API RevenueForecast by Application (2025-2030) & ($ millions)
Table 72. Shandong Anhong Pharmaceutical Basic Information, Afatinib API Manufacturing Base, Sales Area and Its Competitors
Table 73. Shandong Anhong Pharmaceutical Afatinib API Product Portfolios and Specifications
Table 74. Shandong Anhong Pharmaceutical Afatinib API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 75. Shandong Anhong Pharmaceutical Main Business
Table 76. Shandong Anhong Pharmaceutical Latest Developments
Table 77. Lianyungang Runzhong Pharmaceutical Basic Information, Afatinib API Manufacturing Base, Sales Area and Its Competitors
Table 78. Lianyungang Runzhong Pharmaceutical Afatinib API Product Portfolios and Specifications
Table 79. Lianyungang Runzhong Pharmaceutical Afatinib API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 80. Lianyungang Runzhong Pharmaceutical Main Business
Table 81. Lianyungang Runzhong Pharmaceutical Latest Developments
Table 82. Jiangsu Xidi Pharmaceuticals Basic Information, Afatinib API Manufacturing Base, Sales Area and Its Competitors
Table 83. Jiangsu Xidi Pharmaceuticals Afatinib API Product Portfolios and Specifications
Table 84. Jiangsu Xidi Pharmaceuticals Afatinib API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 85. Jiangsu Xidi Pharmaceuticals Main Business
Table 86. Jiangsu Xidi Pharmaceuticals Latest Developments
Table 87. JiangsuTasly Diyi Pharmaceutical Basic Information, Afatinib API Manufacturing Base, Sales Area and Its Competitors
Table 88. JiangsuTasly Diyi Pharmaceutical Afatinib API Product Portfolios and Specifications
Table 89. JiangsuTasly Diyi Pharmaceutical Afatinib API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 90. JiangsuTasly Diyi Pharmaceutical Main Business
Table 91. JiangsuTasly Diyi Pharmaceutical Latest Developments
Table 92.Fresenius Kabi Basic Information, Afatinib API Manufacturing Base, Sales Area and Its Competitors
Table 93.Fresenius Kabi Afatinib API Product Portfolios and Specifications
Table 94.Fresenius Kabi Afatinib API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 95.Fresenius Kabi Main Business
Table 96.Fresenius Kabi Latest Developments
Table 97. Shilpa Medicare Basic Information, Afatinib API Manufacturing Base, Sales Area and Its Competitors
Table 98. Shilpa Medicare Afatinib API Product Portfolios and Specifications
Table 99. Shilpa Medicare Afatinib API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 100. Shilpa Medicare Main Business
Table 101. Shilpa Medicare Latest Developments
Table 102. Clearsynth Labs Basic Information, Afatinib API Manufacturing Base, Sales Area and Its Competitors
Table 103. Clearsynth Labs Afatinib API Product Portfolios and Specifications
Table 104. Clearsynth Labs Afatinib API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 105. Clearsynth Labs Main Business
Table 106. Clearsynth Labs Latest Developments
Table 107. MSN Laboratories Basic Information, Afatinib API Manufacturing Base, Sales Area and Its Competitors
Table 108. MSN Laboratories Afatinib API Product Portfolios and Specifications
Table 109. MSN Laboratories Afatinib API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 110. MSN Laboratories Main Business
Table 111. MSN Laboratories Latest Developments
Table 112. Hetero Labs Basic Information, Afatinib API Manufacturing Base, Sales Area and Its Competitors
Table 113. Hetero Labs Afatinib API Product Portfolios and Specifications
Table 114. Hetero Labs Afatinib API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 115. Hetero Labs Main Business
Table 116. Hetero Labs Latest Developments
Table 117. Alembic Pharmaceuticals Basic Information, Afatinib API Manufacturing Base, Sales Area and Its Competitors
Table 118. Alembic Pharmaceuticals Afatinib API Product Portfolios and Specifications
Table 119. Alembic Pharmaceuticals Afatinib API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 120. Alembic Pharmaceuticals Main Business
Table 121. Alembic Pharmaceuticals Latest Developments
Table 122. Lotus International Basic Information, Afatinib API Manufacturing Base, Sales Area and Its Competitors
Table 123. Lotus International Afatinib API Product Portfolios and Specifications
Table 124. Lotus International Afatinib API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 125. Lotus International Main Business
Table 126. Lotus International Latest Developments
Table 127. Caplin Point Laboratories Basic Information, Afatinib API Manufacturing Base, Sales Area and Its Competitors
Table 128. Caplin Point Laboratories Afatinib API Product Portfolios and Specifications
Table 129. Caplin Point Laboratories Afatinib API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 130. Caplin Point Laboratories Main Business
Table 131. Caplin Point Laboratories Latest Developments
Table 132. Rmpl Pharma LLP Basic Information, Afatinib API Manufacturing Base, Sales Area and Its Competitors
Table 133. Rmpl Pharma LLP Afatinib API Product Portfolios and Specifications
Table 134. Rmpl Pharma LLP Afatinib API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 135. Rmpl Pharma LLP Main Business
Table 136. Rmpl Pharma LLP Latest Developments
LIST OFFIGURES
Figure 1. Picture of Afatinib API
Figure 2. Afatinib API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Afatinib API Sales Growth Rate 2019-2030 (Tons)
Figure 7. Global Afatinib API Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Afatinib API Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Afatinib API Sales Market Share by Country/Region (2023)
Figure 10. Afatinib API Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Purity?99%
Figure 12. Product Picture of Purity<99%
Figure 13. Global Afatinib API Sales Market Share byType in 2023
Figure 14. Global Afatinib API Revenue Market Share byType (2019-2024)
Figure 15. Afatinib API Consumed in Online Sales
Figure 16. Global Afatinib API Market: Online Sales (2019-2024) & (Tons)
Figure 17. Afatinib API Consumed in Offline Sales
Figure 18. Global Afatinib API Market: Offline Sales (2019-2024) & (Tons)
Figure 19. Global Afatinib API Sale Market Share by Application (2023)
Figure 20. Global Afatinib API Revenue Market Share by Application in 2023
Figure 21. Afatinib API Sales by Company in 2023 (Tons)
Figure 22. Global Afatinib API Sales Market Share by Company in 2023
Figure 23. Afatinib API Revenue by Company in 2023 ($ millions)
Figure 24. Global Afatinib API Revenue Market Share by Company in 2023
Figure 25. Global Afatinib API Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Afatinib API Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Afatinib API Sales 2019-2024 (Tons)
Figure 28. Americas Afatinib API Revenue 2019-2024 ($ millions)
Figure 29. APAC Afatinib API Sales 2019-2024 (Tons)
Figure 30. APAC Afatinib API Revenue 2019-2024 ($ millions)
Figure 31. Europe Afatinib API Sales 2019-2024 (Tons)
Figure 32. Europe Afatinib API Revenue 2019-2024 ($ millions)
Figure 33. Middle East & Africa Afatinib API Sales 2019-2024 (Tons)
Figure 34. Middle East & Africa Afatinib API Revenue 2019-2024 ($ millions)
Figure 35. Americas Afatinib API Sales Market Share by Country in 2023
Figure 36. Americas Afatinib API Revenue Market Share by Country (2019-2024)
Figure 37. Americas Afatinib API Sales Market Share byType (2019-2024)
Figure 38. Americas Afatinib API Sales Market Share by Application (2019-2024)
Figure 39. United States Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 40. Canada Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 41. Mexico Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 42. Brazil Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 43. APAC Afatinib API Sales Market Share by Region in 2023
Figure 44. APAC Afatinib API Revenue Market Share by Region (2019-2024)
Figure 45. APAC Afatinib API Sales Market Share byType (2019-2024)
Figure 46. APAC Afatinib API Sales Market Share by Application (2019-2024)
Figure 47. China Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 48. Japan Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 49. South Korea Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 50. Southeast Asia Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 51. India Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 52. Australia Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 53. ChinaTaiwan Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 54. Europe Afatinib API Sales Market Share by Country in 2023
Figure 55. Europe Afatinib API Revenue Market Share by Country (2019-2024)
Figure 56. Europe Afatinib API Sales Market Share byType (2019-2024)
Figure 57. Europe Afatinib API Sales Market Share by Application (2019-2024)
Figure 58. Germany Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 59.France Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 60. UK Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 61. Italy Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 62. Russia Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 63. Middle East & Africa Afatinib API Sales Market Share by Country (2019-2024)
Figure 64. Middle East & Africa Afatinib API Sales Market Share byType (2019-2024)
Figure 65. Middle East & Africa Afatinib API Sales Market Share by Application (2019-2024)
Figure 66. Egypt Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 67. South Africa Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 68. Israel Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 69.Turkey Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 70. GCC Countries Afatinib API Revenue Growth 2019-2024 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Afatinib API in 2023
Figure 72. Manufacturing Process Analysis of Afatinib API
Figure 73. Industry Chain Structure of Afatinib API
Figure 74. Channels of Distribution
Figure 75. Global Afatinib API Sales MarketForecast by Region (2025-2030)
Figure 76. Global Afatinib API Revenue Market ShareForecast by Region (2025-2030)
Figure 77. Global Afatinib API Sales Market ShareForecast byType (2025-2030)
Figure 78. Global Afatinib API Revenue Market ShareForecast byType (2025-2030)
Figure 79. Global Afatinib API Sales Market ShareForecast by Application (2025-2030)
Figure 80. Global Afatinib API Revenue Market ShareForecast by Application (2025-2030)
